chain Innovation and Practice Based on Digital-Intelligent Compound Decoction" came to a successful conclusion. This live broadcast, based on the rapidly growing market pattern of the homology of medicine and food, directly addressed the pain points of the traditional herbal industry. It provided an in-depth interpretation of how DIMT® digital-intelligent compound decoction technology restructures the full-chain process of herbal health industry research and development, production, quality control, and product launch. It also brought new opportunities and a new future for technology to empower traditional herbs to the on-site industry experts, business representatives, and health practitioners.
Currently, as the Healthy China strategy continues to advance and national health consumption continues to upgrade, the concept of "medicinal and edible homology" has become a core growth force in the broader health industry. Driven by policy dividends, younger consumer demographics, and refined demand, the industry has entered a new stage of high-quality development. According to data from the "2026 China Medicinal and Edible Homologous Health Food Market Research Report," the market size of medicinal and edible homology is expected to exceed 760 billion yuan in 2026 and reach 820 billion yuan in 2027, with an average annual growth rate of about 10%. The strong growth potential fully confirms that medicinal and edible homology is the future theme of the health industry.
Facing the widespread challenges of product homogenization, formula homogenization, and efficacy homogenization in the industry, the herbal health industry is accelerating its transition away from low-level raw material competition and comprehensively shifting towards a high-quality development track centered on technological innovation. Leveraging its long-term accumulation in the herbal field and continuous investment in scientific research, the company has taken the lead in establishing a five-step closed-loop research system. Through standardized, digitalized, and scientific means, it has completely changed the current situation where traditional decoction relies on experience and is difficult to quantify, driving the industry to comprehensively upgrade from "experience-driven" to "scientifically controllable".
The digital and intelligent raw material control platform establishes a digital traceability system from the source, ensuring the stability of raw material quality. It provides full control over the entire process, from planting, harvesting, processing to warehousing, laying a solid foundation for quality;
The AI-driven drug pair R&D simulation platform utilizes deep learning algorithms to simulate compatibility rules, significantly shortening the R&D cycle, reducing experimental costs, and enhancing the efficiency and success rate of formula development;
DCS intelligent online control production line achieves full-process automated monitoring and precise adjustment, collects production data in real time, ensures consistency in the decoction process, and solves the problem of batch fluctuation;
The intelligent preparation transformation and customization platform, leveraging flexible production technology, caters to the needs of various scenarios such as home use, cinema, and gift giving. It supports personalized formula customization, truly achieving precise health supply and aligning with the current trend of personalized and refined consumption;
Relying on the mature implementation of DIMT® digital and intelligent compound decoction technology, the company will launch nine major categories of digital and intelligent compound decoction annual new products in 2026. The new products are optimized and upgraded from classic formulas, creating brand-exclusive compound concentrated liquids. They have undergone rigorous human trial verification, demonstrating clear efficacy, convenient administration, and better taste, covering mainstream directions such as qi and blood regulation, weight management, and brain health. The products precisely meet the market demand for food and medicine homology, forming differentiated advantages with digital and intelligent technology, providing consumers with more scientific, efficient, and assured herbal health choices.
Based on the essence of herbal medicine and adhering to our original aspiration of innovation, Taiyi Health closely follows market trends and continuously delves into the innovation of digital and intelligent compound decoction technology. With a full-chain digital and intelligent solution, we aim to address industry pain points and enhance product experience. Collaborating with partners across the industry, we strive to build a new ecosystem for the herbal health industry, allowing the wisdom of thousands of years of herbal medicine to benefit consumer health in a more scientific and convenient way, and propelling the food and medicine homology industry towards a new journey.